Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials.

What the trial testedas reported · 4,045 people · 2015

Range includes no effect

−19%−59% to +61%

Bigger than 4 in 10 on the map

As reported

OR 0.81, 95% CI 0.41–1.61

the abstract, start to end

… cardiac catherization (I = 0%, OR = 0.81, 95% CI = 0.41-1.61, P = …

← favours treatmentfavours comparator →

could be chance

Kidney outcomes

OR 0.810.41–1.61

StatinsCardiac procedures & devicesKidney outcomes

1 / 3

2015

2016

2017

2018

2019

2020

2021

this paperpooled itcites it